{
  "Variants Include": [
    {
      "Gene": "PARKIN",
      "variants": [
        {
          "HGVS": "NM_001130829.1:c.143G>T",
          "cDNA Change": {
            "transcript": "NM_001130829.1",
            "ref": "G",
            "alt": "T",
            "position": "143"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "V",
            "position": "48"
          },
          "Description in input context": "p.G48V"
        },
        {
          "HGVS": "NM_001130829.1:c.143G>C",
          "cDNA Change": {
            "transcript": "NM_001130829.1",
            "ref": "G",
            "alt": "C",
            "position": "143"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "48"
          },
          "Description in input context": "p.G48R"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005256"
  },
  "Experiment Method": [
    {
      "Assay Method": "X-ray Crystallography",
      "Material used": {
        "Material Source": "Recombinant Proteins",
        "Material Name": "Parkin RBR domain and PINK1-13",
        "Description": "Structural analysis of Parkin's RBR domain and PINK1-13 interactions using recombinant proteins."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001130829.1:c.143G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural disruption",
          "Result Description": "The p.G48V variant in Parkin's RBR domain exhibited altered conformational stability, reducing its interaction with PINK1-13."
        },
        {
          "Variant": "NM_001130829.1:c.143G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural disruption",
          "Result Description": "The p.G48R variant showed significant loss of RBR domain flexibility, impairing PINK1-13 binding."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Functional Assay (Ubiquitination Activity)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells overexpressing Parkin variants",
        "Description": "Functional assays in HEK293 cells overexpressing Parkin p.G48V and p.G48R variants to assess ubiquitination activity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130829.1:c.143G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "p.G48V reduced ubiquitination of PINK1-13 substrates by 60% compared to wild-type Parkin."
        },
        {
          "Variant": "NM_001130829.1:c.143G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "p.G48R completely abolished ubiquitination activity of Parkin."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type Parkin was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination activity â‰¥80% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination activity <50% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}